Simultaneous expression of cancer stem cell-like properties and cancer-associated fibroblast-like properties in a primary culture of breast cancer cells

Cancers

Volumn 6, Issue 3, 2014, Pages 1570-1578

  Ishikawa, Mami ^a   Inoue, Takahiro ^a   Shirai, Takuma ^a   Takamatsu, Kazuhiko ^a   Kunihiro, Shiori ^a   Ishii, Hirokazu ^a   Nishikata, Takahito ^a  

^a KONAN UNIVERSITY   (Japan)

Author keywords

Cancer stem cell; Cancer associated fibroblast; Epithelial mesenchymal transition; Glycolysis; HIF1A

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOMERASE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; NUCLEAR FACTOR KAPPA B2; NUCLEIC ACID BINDING PROTEIN; PHOSPHOGLYCERATE MUTASE 1; PROTEIN BNIP3; PYRUVATE KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BNIP3 GENE; BREAST CANCER CELL LINE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER ASSOCIATED FIBROBLAST; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENICITY; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; GAPDH GENE; GENE; GENE OVEREXPRESSION; GLYCOLYSIS; HIF1A GENE; HUMAN; HUMAN CELL; LDHA GENE; NFKB2 GENE; PGAM1 GENE; PKM2 GENE; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TUMOR GROWTH;

EID: 84927921210     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers6031570     Document Type: Article

References (18)

1. Fedele, C.; Tothill, R.W.; McArthur, G.A. Navigating the challenge of tumor heterogeneity in cancer therapy. Cancer Discov. 2014, 4, 146-148.
2. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
3. Orimo, A.; Gupta, P.B.; Sgroi, D.C.; Arenzana-Seisdedos, F.; Delaunay, T.; Naeem, R.; Carey, V.J.; Richardson, A.L.; Weinberg, R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121, 335-348.
4. Pietras, K.; Ostman, A. Hallmarks of cancer: Interactions with the tumor stroma. Exp. Cell Res. 2010, 316, 1324-1331.
5. Bhowmick, N.A.; Neilson, E.G.; Moses, H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 18, 332-337.
6. Tripathi, M.; Billet, S.; Bhowmick, N.A. Understanding the role of stromal fibroblasts in cancer progression. Cell Adhes. Migr. 2012, 6, 231-235.
7. Nishikata, T.; Ishikawa, M.; Matsuyama, T.; Takamatsu, K.; Fukuhara, T.; Konishi, Y. Primary culture of breast cancer: A model system for epithelial-mesenchymal transition and cancer stem cells. Anticancer Res. 2013, 33, 2867-2874.
8. Sappino, A.P.; Skalli, O.; Jackson, B.; Schürch, W.; Gabbiani, G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 1988, 41, 707-712.
9. Xouri, G.; Christian, S. Origin and function of tumor stroma fibroblasts. Semin. Cell Dev. Biol. 2010, 21, 40-46.
10. Eck, S.M.; Côté, A.L.; Winkelman, W.D.; Brinckerhoff, C.E. CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells. Mol. Cancer Res. 2009, 7, 1033-1044.
11. Franco, O.E.; Shaw, A.K.; Strand, D.W.; Hayward, S.W. Cancer associated fibroblasts in cancer pathogenesis. Semin. Cell Dev. Biol. 2010, 21, 33-39.
12. Zhong, H.; de Marzo, A.M.; Laughner, E.; Lim, M.; Hilton, D.A.; Zagzag, D.; Buechler, P.; Issacs, W.B.; Semenza, G.L.; Simons, J.W. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 1999, 59, 5830-5835.
13. Martinez-Outschoorn, U.E.; Trimmer, C.; Lin, Z.; Whitaker-Menezes, D.; Chiavarina, B.; Zhou, J.; Wang, C.; Pavlides, S.; Martinez-Cantarin, M.P.; Capozza, F.; et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NF-κB activation in the tumor stromal microenvironment. Cell Cycle 2010, 9, 3515-3533.
14. Bonuccelli, G.; Whitaker-Menezes, D.; Castello-Cros, R.; Pavlides, S.; Pestell, R.G.; Fatatis, A.; Witkiewicz, A.K.; vander Heiden, M.G.; Migneco, G.; Chiavarina, B.; et al. The reverse Warburg effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010, 9, 1960-1971.
15. Carreira, S.; Goodall, J.; Aksan, I.; la Rocca, S.A.; Galibert, M.D.; Denat, L.; Larue, L.; Goding, C.R. Mitf cooperates with Rb1 and activates p21(Cip1) expression to regulate cell cycle progression. Nature 2005, 433, 764-769.
16. Shintani, Y.; Abulaiti, A.; Kimura, T.; Funaki, S.; Nakagiri, T.; Inoue, M.; Sawabata, N.; Minami, M.; Morii, E.; Okumura, M. Pulmonary fibroblasts induce epithelial mesenchymal transition and some characteristics of stem cells in non-small cell lung cancer. Ann. Thorac. Surg. 2013, 96, 425-433.
17. Kiyonari, H.; Kaneko, M.; Abe, S.; Aizawa, S. Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL/6N mouse strain with high efficiency and stability. Genesis 2010, 48, 317-327.
18. Favata, M.F.; Horiuchi, K.Y.; Manos, E.J.; Daulerio, A.J.; Stradley, D.A.; Feeser, W.S.; van Dyk, D.E.; Pitts, W.J.; Earl, R.A.; Hobbs, F.; et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273, 18623-18632.